KCNN4 and coronary artery disorder: Although the higher concentration of simvastatin may have influence on KCa3.1, the concentration of the selected was postulated by the oral dosage used by CAD patients, and it was within the effective range and was clarified in other labs (Seto et al., 2007; Chan et al., 2012; Kazama et al., 2014; Sohn et al., 2017).